KITE PHARMA INC's ticker is KITE and the CUSIP is 49803L109.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $515,000 | -94.7% | 2,864 | -96.9% | 0.07% | -95.8% |
| Q2 2017 | $9,638,000 | +26.6% | 92,970 | -4.1% | 1.71% | +3.4% |
| Q1 2017 | $7,610,000 | +89.6% | 96,960 | +8.3% | 1.66% | +49.9% |
| Q4 2016 | $4,013,000 | -67.1% | 89,502 | -59.0% | 1.11% | -58.6% |
| Q3 2016 | $12,195,000 | +5.4% | 218,312 | -5.6% | 2.67% | -24.3% |
| Q2 2016 | $11,569,000 | -1.8% | 231,385 | -9.8% | 3.53% | -32.9% |
| Q1 2016 | $11,778,000 | -38.9% | 256,550 | -18.0% | 5.26% | +6.5% |
| Q4 2015 | $19,283,000 | +30.4% | 312,937 | +17.8% | 4.94% | +12.7% |
| Q3 2015 | $14,791,000 | -29.1% | 265,640 | -22.4% | 4.38% | +15.8% |
| Q2 2015 | $20,863,000 | +8.4% | 342,188 | +2.5% | 3.78% | -19.6% |
| Q1 2015 | $19,254,000 | -16.4% | 333,813 | -16.5% | 4.71% | -22.6% |
| Q4 2014 | $23,043,000 | +80.8% | 399,571 | -10.7% | 6.08% | +59.1% |
| Q3 2014 | $12,746,000 | – | 447,237 | – | 3.82% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wildcat Capital Management, LLC | 2,358,084 | $105,736,000 | 48.63% |
| BAINCO INTERNATIONAL INVESTORS | 1,151,540 | $51,635,000 | 8.76% |
| Coastal Bridge Advisors, LLC | 250,040 | $11,212,000 | 4.36% |
| NEXTHERA CAPITAL LP | 150,000 | $6,726,000 | 3.94% |
| Casdin Capital, LLC | 94,000 | $4,215,000 | 3.48% |
| MENORA MIVTACHIM HOLDINGS LTD. | 1,258,899 | $56,449,000 | 2.90% |
| DIALECTIC CAPITAL MANAGEMENT, LP | 85,000 | $3,812,000 | 2.14% |
| SECTORAL ASSET MANAGEMENT INC | 372,223 | $16,690,000 | 1.85% |
| ARK Investment Management | 97,313 | $4,364,000 | 1.59% |
| BB BIOTECH AG | 800,000 | $35,872,000 | 1.33% |